Risks and benefits of prophylactic antimalarial drugs
BMJ
.
1989 Dec 2;299(6712):1400.
doi: 10.1136/bmj.299.6712.1400-a.
Authors
R Mallett
,
R Pye
PMID:
2513979
PMCID:
PMC1838225
DOI:
10.1136/bmj.299.6712.1400-a
No abstract available
Publication types
Case Reports
Comment
Letter
MeSH terms
Chloroquine / adverse effects*
Humans
Male
Middle Aged
Psoriasis / chemically induced*
Substances
Chloroquine